276 related articles for article (PubMed ID: 38424367)
1. Nanocarrier-Mediated Drug Delivery via Inhalational Route for Lung Cancer Therapy: A Systematic and Updated Review.
Ara N; Hafeez A
AAPS PharmSciTech; 2024 Feb; 25(3):47. PubMed ID: 38424367
[TBL] [Abstract][Full Text] [Related]
2. Surface-engineered smart nanocarrier-based inhalation formulations for targeted lung cancer chemotherapy: a review of current practices.
Yu XY; Jin X; Shou ZX
Drug Deliv; 2021 Dec; 28(1):1995-2010. PubMed ID: 34569401
[TBL] [Abstract][Full Text] [Related]
3. Nanotechnology-based inhalation treatments for lung cancer: state of the art.
Ahmad J; Akhter S; Rizwanullah M; Amin S; Rahman M; Ahmad MZ; Rizvi MA; Kamal MA; Ahmad FJ
Nanotechnol Sci Appl; 2015; 8():55-66. PubMed ID: 26640374
[TBL] [Abstract][Full Text] [Related]
4. Hyaluronic acid-based drug nanocarriers as a novel drug delivery system for cancer chemotherapy: A systematic review.
Salari N; Mansouri K; Valipour E; Abam F; Jaymand M; Rasoulpoor S; Dokaneheifard S; Mohammadi M
Daru; 2021 Dec; 29(2):439-447. PubMed ID: 34499323
[TBL] [Abstract][Full Text] [Related]
5. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
6. Nanotechnology-Assisted Metered-Dose Inhalers (MDIs) for High-Performance Pulmonary Drug Delivery Applications.
Kumar R; Mehta P; Shankar KR; Rajora MAK; Mishra YK; Mostafavi E; Kaushik A
Pharm Res; 2022 Nov; 39(11):2831-2855. PubMed ID: 35552983
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary Delivery of Anticancer Drugs via Lipid-Based Nanocarriers for the Treatment of Lung Cancer: An Update.
Abdulbaqi IM; Assi RA; Yaghmur A; Darwis Y; Mohtar N; Parumasivam T; Saqallah FG; Wahab HA
Pharmaceuticals (Basel); 2021 Jul; 14(8):. PubMed ID: 34451824
[TBL] [Abstract][Full Text] [Related]
8. Lipid-Based Nanocarriers for Targeted Gene Delivery in Lung Cancer Therapy: Exploring a Novel Therapeutic Paradigm.
Beigi A; Naghib SM; Matini A; Tajabadi M; Mozafari MR
Curr Gene Ther; 2024 May; ():. PubMed ID: 38778601
[TBL] [Abstract][Full Text] [Related]
9. Nanotechnological Systems and Lung: A Perfect Combination for Lung Pharmaceutical Applications.
Santonocito D; Puglia C
Curr Med Chem; 2023; 30(6):725-743. PubMed ID: 36043745
[TBL] [Abstract][Full Text] [Related]
10. Potential enhancement and targeting strategies of polymeric and lipid-based nanocarriers in dermal drug delivery.
Kahraman E; Güngör S; Özsoy Y
Ther Deliv; 2017 Nov; 8(11):967-985. PubMed ID: 29061106
[TBL] [Abstract][Full Text] [Related]
11. Controlled drug release from lung-targeted nanocarriers via chemically mediated shell permeabilisation.
Chen H; Woods A; Forbes B; Jones S
Int J Pharm; 2016 Sep; 511(2):1033-41. PubMed ID: 27506512
[TBL] [Abstract][Full Text] [Related]
12. A Mini-review on New Developments in Nanocarriers and Polymers for Ophthalmic Drug Delivery Strategies.
Sharma Y; Patel P; Kurmi BD
Curr Drug Deliv; 2024; 21(4):488-508. PubMed ID: 37143264
[TBL] [Abstract][Full Text] [Related]
13. Vesicular Nanocarriers: A Potential Platform for Topical/Transdermal Delivery of Antibiotics.
Chadha M; Malik DS
Recent Pat Nanotechnol; 2024 Jan; ():. PubMed ID: 38204233
[TBL] [Abstract][Full Text] [Related]
14. Nanotechnology-based alternatives for the topical delivery of immunosuppressive agents in psoriasis.
Gomes GS; Frank LA; Contri RV; Longhi MS; Pohlmann AR; Guterres SS
Int J Pharm; 2023 Jan; 631():122535. PubMed ID: 36566826
[TBL] [Abstract][Full Text] [Related]
15. Injectable Drug-Loaded Nanocarriers for Lung Cancer Treatments.
Yu HP; Aljuffali IA; Fang JY
Curr Pharm Des; 2017; 23(3):481-494. PubMed ID: 28292243
[TBL] [Abstract][Full Text] [Related]
16. Emerging Nanotechnology-based Therapeutics: A New Insight into Promising Drug Delivery System for Lung Cancer Therapy.
Verma R; Rao L; Nagpal D; Yadav M; Kumar V; Kumar V; Kumar H; Parashar J; Bansal N; Kumar M; Pandey P; Mittal V; Kaushik D
Recent Pat Nanotechnol; 2023 Aug; ():. PubMed ID: 37537775
[TBL] [Abstract][Full Text] [Related]
17. Recent Advances in Lipid-based Nanodrug Delivery Systems in Cancer Therapy.
Layek B; Gidwani B; Tiwari S; Joshi V; Jain V; Vyas A
Curr Pharm Des; 2020; 26(27):3218-3233. PubMed ID: 32568015
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary delivery of anti-inflammatory agents.
Ali ME; McConville JT; Lamprecht A
Expert Opin Drug Deliv; 2015 Jun; 12(6):929-45. PubMed ID: 25534260
[TBL] [Abstract][Full Text] [Related]
19. Recent trends in targeted delivery of smart nanocarrier-based microbial enzymes for therapeutic applications.
Jangra N; Kawatra A; Datten B; Gupta S; Gulati P
Drug Discov Today; 2024 Apr; 29(4):103915. PubMed ID: 38340953
[TBL] [Abstract][Full Text] [Related]
20. Nanocarrier Mediated Intranasal Drug Delivery Systems for the Management of Parkinsonism: A Review.
Kapoor A; Hafeez A; Kushwaha P
Curr Drug Deliv; 2024; 21(5):709-725. PubMed ID: 37365787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]